Multicenter Real-life Observational Study Switched Aflibercept or Ranibizumab to Faricimab in Patients With AMD.

Exclusion Criteria

• •Severe myopia (axial length \> 26 mm or sphere \< - 6 dioptres).
• •* Presence of angioid striae.
• •* Presence of moderate or more severe diabetic retinopathy.
• •* History of diabetic macular edema.
• •* History of uveitis.
• •* Previous retinal vein occlusion (branch or central vein).
• •* History of pseudovitelliform macular dystrophy.
• •* Patient under guardianship or trusteeship
• •* Pregnant or breast-feeding woman